ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$15.74
+3.01%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 33.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.72x
- Price / sales
- 51.51x
- Price / cash flow
- -17.48x
Enterprise value
- Enterprise value
- $807.5M
- EV / sales
- 41.03x
- EV / EBITDA
- -37.61x
- EV / EBIT
- -36.22x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026